New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Marc Keats appointed President of Taiko Healthcare

September, 2002 – Marc D. Keats has been named President of Taiko Healthcare, Inc., a division of Taiko Pharmaceutical Co., Ltd., effective May, 2002. He will be responsible for overseeing all Taiko Healthcare operations in the U.S. and Japan, including both the natural health retail and e-commerce markets for the sale of the Tenshin Essentials product line in the U.S. An employee of the parent company since 1998, the most recent position Keats held was Manager of Taiko Pharmaceutical where he was responsible for the registration of Taiko’s supplements in overseas markets, and co-supervision of Phase II studies for Seirogan in the U.S. Prior to that, his management responsibilities included the development of new markets for animal healthcare products in Japan, as well as the development of a cosmetic ingredients market and establishment of several strategic ventures between Canadian and U.S. suppliers and Japanese manufacturers.

The Tenshin Essentials line includes Seirogan, for gentle, effective relief from mild diarrhea, Nattokin, to help maintain healthy digestion, and Elastase, a cholesterol-reducing enzyme to help maintain optimal heart health. The Tenshin Essentials line is distributed by Taiko Healthcare and manufactured by Taiko Pharmaceuticals. Taiko Healthcare’s customers benefit from the resources provided by the company’s pharmaceutical background. Full research facilities conduct research on raw materials and the Quality Control and Quality Assurance divisions guarantee that all final products meet Taiko’s strict standards for Good Manufacturing Practices (GMPs).

# # #

Uncle Matt Puts OTA In Its Basket!

Clermont, FL (September 9, 2002) Uncle Matt’s Organic, Florida’s premier organic juice company, announced today a fundraising promotion to help the Organic Trade Association’s kick off of its new affiliated nonprofit organization, The Center for Organic Education and Promotion. A long time OTA member, Uncle Matt’s Organic will donate 10% of gross sales on every organic fruit gift basket sold during the months of November through mid-January. “This is our commitment to the OTA and we are pleased to support its outreach efforts to educate the public about the benefits of organic agriculture,” says Matt McLean, CEO of Uncle Matt’s.

Last winter, the company announced its online “Country Store” at (or call 866.626.4613) for consumers to purchase premium organic citrus gift fruit boxes to send to family, friends and corporate clients. Products have been offered in two sizes: the larger 36-38 pound selection and the medium box of 18-20 pounds of fruit. In addition, the company is offering a new special one-layer gift box that promises to be the perfect sampler to fit anyone’s budget. The “easy to order” web site also allows consumers the ability to “build their own gift box”. Product choices include “Orange Lovers Delight,” “Grapefruits Galore,” “Tangelo Tango” and “Totally Tangerines”.

Sales will help support OTA’s new Center for Organic Education and Promotion, which has applied for recognition as a charitable organization. Its mission is to educate the public about the importance of organic agriculture and its products in promoting good health, quality of life and the creation of a sustainable global environment. OTA’s Executive Director Katherine DiMatteo says “The center fulfills a long-held goal shared by many in the organic community to have a nonprofit organization that can increase knowledge and awareness of organic agriculture.

We hope this outreach will help educate individuals about the link between organic agricultural practices and protecting the environment and public health.” The center will partner with research groups to bring together all of the latest research and science-based information about the benefits of organic agriculture and then create compelling education programs. The center as a nonprofit charitable organization will have access to grants, funds and donations and contributions may be fully deductible to the full extent of the law.

Matt McLean is available for comment or interview by calling 352.394.8737.

CV Technologies Closes Private Placements

Edmonton, Alberta - CV Technologies Inc. (TSX-VEN:CVQ) announced today the closing of several private placements for gross proceeds to the corporation of $67,837.50. Pursuant to these private placements CVT will issue, pending exchange approval, 678,375 common shares at $0.10 per common share of the corporation, and 553,375 warrants. Each warrant entitles the holder thereof to purchase one additional Common Share of the corporation at the exercise price of $0.10 at any time prior to September 25, 2002.

Mr. Kim Lucas stated that this capital investment will aid in CVT's marketing efforts with its natural health products, such as COLD-FX(r), AD-FX(r), REMEMBER-FX(r), CELL-FX(r) and PRESSURE-FX(r). While it is a small investment, it comes at a tough time for financing for the industry and represents the markets continued confidence in CVT's business plan: to continue to market and sell its products in North America, while aggressively seeking business partner(s) for US and World-wide success. CV Technologies may continue to pursue further private placements in the future, market conditions permitting.

More information about CV Technologies, Inc. can be found at and

This news release contains forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from the statements made. For this purpose, any statements that are contained herein that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words "believes", "anticipates", "plans", "intends", "expects" and similar expressions are intended to identify forward-looking statements. Such risks and uncertainties include, but are not limited to, the need for capital, changing market conditions, completion of clinical trials, patient enrolment rates, uncertainty of pre-clinical, retrospective and early clinical trial results, the establishment of manufacturing processes and new corporate alliances, the timely development, regulatory approval and market acceptance of the Company's products, and other risks detailed from time to time in the Company's filings with Canadian securities authorities.


For further information, please contact:
Ivan Dijkstra, M.B.A., B.Sc., Director of Operations,
(780) 431-0431 ext. 224, [email protected]

Weider Announces Fiscal 2003 First Quarter Results

SALT LAKE CITY, Sep 26, 2002 (BUSINESS WIRE) -- Weider Nutrition International, Inc. (NYSE:WNI) today announced results for the three-month period ended August 31, 2002.

Weider Nutrition's net sales were $76.2 million for the fiscal 2003 first quarter, compared to $80.7 million for the fiscal 2002 first quarter. As previously announced, the Company sold its American Body Building(TM) and Science Foods(R) brands in July 2002.

Excluding a one-time charge explained below, Weider Nutrition recorded net income of $4.5 million or $0.17 per share (diluted) for the fiscal 2003 first quarter, compared to a net loss of $352,000 or $0.01 per share for the same period a year ago. Net income excludes the cumulative after-tax effect of adopting a new accounting principle. SFAS No. 142 establishes accounting and reporting standards for goodwill and other intangible assets. The adoption of SFAS No. 142 resulted in a one-time charge of $15.4 million, representing write-off of goodwill, during the quarter. Including this charge, Weider Nutrition reported a net loss of $10.9 million or $0.42 per share. Gross profit percentage was 39.6% for the fiscal 2003 first quarter, compared to 32.9% for the fiscal 2002 first quarter. Consolidated operating margin was 10.8% and 1.5% for fiscal 2003 and 2002 first quarters, respectively.

Bruce Wood, president and CEO, stated, "Weider again recorded improved operating results, including an increase in both gross margin and operating margin performance. This improvement reflects our proactive measures to increase profitability. We continue to see the benefits of our lower cost structure, allowing us to move toward our long-term goal of building shareholder value. We are aggressively working to address continuing soft industry conditions, as well as ongoing pressure from private label competition on our flagship Schiff(R) Move Free(R) business, with new product and marketing plans for fiscal 2003."

Conference Call Information

Weider Nutrition International will hold a conference call today, September 26, 2002 at 11 a.m. ET. The U.S. domestic access number is 800/982-3472. International participants should dial 703/871-3022. Please call in approximately ten minutes in advance. The conference call will be broadcast live over the Internet at WWW.WEIDER.COM. If you do not have Internet access, a replay of the call will be available by dialing 888/266-2081 and entering access code 6217482. The telephone replay will be available through September 28, 2002 and the web casting through October 6, 2002.

About Weider Nutrition

Weider Nutrition International, Inc. develops, manufactures, markets and sells branded and private label vitamins, nutritional supplements and sports nutrition products in the United States and throughout the world and sells a line of sports apparel in Europe. To learn more about Weider, please visit the Web site WWW.WEIDER.COM.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as amended, that are based on management's beliefs and assumptions, current expectations, estimates, and projections. These statements are subject to risks and uncertainties, certain of which are beyond the company's ability to control or predict, and, therefore, actual results may differ materially. Weider Nutrition disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

Important factors that may cause these forward looking statements to be false include, but are not limited to: the inability to achieve cost savings and operational efficiencies through reorganization, dependence on individual products, the inability to successfully restructure our Haleko business unit and make it profitable, the inability to successfully utilize available cash resulting from suspension of the Company's quarterly dividend, dependence on individual customers, the impact of competitive products and pricing (including private label), market and industry conditions (including pricing, demand for products, level of trade inventories and raw materials availability and pricing), the success of product development and new product introductions into the marketplace, changes in laws and regulations, litigation and government regulatory action against the Company, lack of available product liability insurance for products containing ephedra, uncertainty of market acceptance of new products, adverse publicity regarding the consumption of nutritional supplements, changes in accounting standards, and other factors indicated from time to time in the company's SEC reports, copies of which are available upon request from the company's investor relations department or may be obtained at the SEC's website (WWW.SEC.GOV).

New Zealand Complementary Health Products Industry Applauds Inquiry

The President of the National Nutritional Foods Association of New Zealand, Bill Bracks, applauds the parliamentary oppositions' stand on defending New Zealand's Complementary Health Products industry in forcing a Select Committee review of the appropriate regulation of Healthcare Products.

Mr Bracks, who is also chairman of Comvita New Zealand Limited, in speaking from Australia says the determined thrust of the MOH toward the introduction of Australia's TGA (Therapeutic Goods Administration) prescriptive and costly regulatory regime to regulate the New Zealand industry is totally unwarranted given the industry's long history of consumer safety and industry responsibility.

Historically the New Zealand industry has displayed duty of care and responsibility wherever potential reaction or caution is recognized. The voluntary use of warnings on product labeling to ensure public health and safety is standard practice.

Mr Bracks says, "It is ironic that without reference to the regulators the industry can voluntarily place warnings on its packaging but it cannot make any therapeutic claim or indeed tell consumers what a product will beneficially do or what to use it for. In today's enlightened environment it is an affront to consumers understanding and intelligence to suggest public health is at risk from a fifty year old $200 million industry that has grown from zero purely by reputation and word of mouth. Quality and safety speak for themselves."

Bracks continues, "Under the Australian system the trade off for heavy handed, cost intensive regulation is a limited capacity to make claims and inform the public. The catch is the higher the claim the higher the fees paid to the regulator all in the name of public safety. Talking to people working under the Australian system is a disheartening experience."

Regulations never prevented cowboys or criminals from breaking the law. They merely control the law-abiding community and set up penalties for those who are caught breaking the rules. It is a commercial fact of life that no sensible business person would risk their company's image and reputation with consumers by putting public health in jeopardy. The penalty for doing so far outweighs any that a regulator may exact," says Bracks.

The NNFA as an industry body by definition is dedicated to the wellness and safety of New Zealanders. It's very existence is testimony to an ethical gathering of industry representatives who do not want anything but a first rate industry to grow on the back of it's outstanding historical past. The industry does not want New Zealand's unique and often cutting edge technology in Complementary Health products dealt with by Aussie Rules.

In conclusion Bracks says, "The New Zealand Complementary Health Industry enjoys a large growing trade in exports and tourism on the back of our image as a country that is clean green and reliable for high quality healthcare products. Surely this is testimony in itself to the safety and integrity of products from a top performing industry.

Politicians need to understand this and be encouraging an industry that contributes to a healthier nation and the health of others around the world.

The NNFA looks forward to full participation in the inquiry to help ensure that an appropriate evidence-based, risk proportionate and affordable regulatory environment is developed.


USP to Unveil New DSVP Mark during ExpoEast Conference

John Fowler, chief operating officer of the United States Pharmacopiea (USP), will unveil the new USP DSVP certification mark. In addition, V. Srini Srinivasan, vice president of the Dietary Supplement Verification Program (DSVP), will provide an overview and update about the program, and Neil G. Reay, director of sales and marketing for DSVP, will discuss how the new mark will impact the dietary supplement industry.

Friday, Oct. 4, 2002
9 a.m. to 11 a.m. EST

The National Press Building
Holeman Lounge
529 14th St. N.W., 13th Floor,
Washington, D.C. 20045

Presented by USP in conjunction with the Natural Products ExpoEast

Program Information:
For further information about the unveiling of the DSVP certification mark or to schedule an interview, please call Sherrie Borden, USP's director of public relations, at 301-816-8268.

RSVP: To attend the unveiling and media conference, please register by e-mail to [email protected]

# # # #

USP-The Standard of Quality

USP is a non-government organization that promotes the public health by establishing state-of-the-art standards to ensure the quality of medicines and other health care technologies. These standards are developed by a unique process of public involvement and are recognized worldwide. In addition, USP has public health programs that focus on promoting optimal health care, including the Dietary Supplement Verification Program (DSVP), Health Care Information, and Patient Safety. USP is a not-for-profit organization that achieves its goals through the contributions of volunteers representing pharmacy, medicine, and other health care professions, as well as science, academia, government, the pharmaceutical industry, and consumer organizations. For more information, visit


Introducing Enjoy Life Foods, LLC: Allergy Free Food Product Company

CHICAGO, IL - With at least 30 million people suffering from some sort of food intolerance, according to the US Center for Disease Control, the demand for prepared foods that don't aggravate health conditions is growing.

Inspired by one of the founder's mother, Joyce, who baked her way back to health after struggling for years with Multiple Sclerosis, Enjoy Life Foods is preparing to introduce its new line of great-tasting, all natural foods that are free of common allergens. They have raised the bar on “gluten-free” by making ready-made foods that are truly delicious, nutritious and safe -- great for multiple allergies, intolerances, and a wealth of other health conditions.

This fall Enjoy Life Foods will launch a line of cookies, bagels, snack bars and more. The products will not only be distinctive by what they leave out (NO wheat, gluten, dairy, casein, eggs, corn, soy, peanuts, artificial preservatives or other additives), but by what they include. The bagel and bar products will be fortified with vitamins and minerals at levels on par or above what is in enriched wheat products (specifically: folic acid, b6, b12, zinc, iron, thiamin, riboflavin, niacin, magnesium, and calcium), making Enjoy Life among the very first companies to fortify gluten-free foods.

Additionally, the company uses nutrient-rich ingredients like amaranth, flax, quinoa and other seeds to enhance the fiber, protein and essential fatty acids content in its products. This is also unique since most gluten-free foods are just made from rice flour, and thus lack fiber and other nutrients. Enjoy Life products are low in saturated fat, cholesterol and sodium and are naturally sweetened. All ingredients are non-GMO and certified kosher.

Another important feature of the company is that the bakery has been built from scratch, insuring no inadvertent product contamination from, for example, peanuts or wheat / gluten.

Foods made without common allergens are important to people dealing with a wide variety of medical conditions (celiac disease, autism, and type 1 diabetes, to name a few), as well as allergies and food intolerances. Specialized foods are also appealing to people on rotation & elimination diets, and to vegans. Usually, foods made without wheat, eggs, dairy, and nuts are loaded with unhealthy ingredients like hydrogenated oils or refined white sugars. Even so, they are not generally very tasty. Enjoy Life distinguishes itself by creating products that meet strict health requirements, but are delicious as well.

By late October the company will be selling their products in natural & specialty food stores, online and in select health care practitioners’ offices. The company's website, will direct people to stores offering the products, or offer online ordering for areas where the product is not yet available.

Enjoy Life Foods was founded by Scott Mandell, President and Bert Cohen. Cindy Kaplan serves as Marketing Director and the wizard in the kitchen is Tom Horne.

- END -

Cindy Kaplan
(773) 889-5070
[email protected]

Forbes Medi-Tech's Reducol on FOX TV

Forbes Medi-Tech's Reducol(TM) is a cholesterol-lowering ingredient included in a dietary supplement called "Cholest-Off" by Pharmavite's Nature Made. Cholest-Off has been receiving a tremendous amount of praise and media attention. The link below is a collection of media clips from FOX TV networks gathered over the past few weeks. Reducol is gaining credibility and exposure as a cholesterol-lowering agent. Look for the Reducol(TM) logo during the clips! (Windows Media Player Format)

Degussa BioActives Launches, a Web Site Focusing on Creatine

Degussa BioActives, one of the leading producers of creatine products under the brand name Creapure, recently launched a Web site offering comprehensive information on creatine. At, users find information on all aspects of Creapure, including the product's history, production, and applications.

The site pays special attention to aspects of food safety and provides detailed information on the subject. Visitors to the site can access technical data sheets as well. Company brochures and relevant articles drawn from industry journals present additional sources of information. Frequently asked questions are grouped together so users can find a quick answer to the most common queries. There are also suggestions for further reading.

The new Web site adds another important tool to the brand management activities of Degussa BioActives and strengthens the company's focus on sports nutrition. Creapure, a brand developed and owned by Degussa BioActives, is the most popular name for creatine monohydrate and is associated with the highest quality in creatine monohydrate products. As a dietary supplement, Creapure contributes to an improvement of general health, which makes it a very useful nutritional supplement for people of all ages.

Degussa BioActives specializes in a wide range of health-promoting ingredients for the food and dietary supplement industry. With clinical studies, assistance in securing regulatory approval and market support, Degussa BioActives actively contributes to the success of the company's customers.

Technical information on the full line of Degussa BioActives ingredients can be found on the company's web site at

Degussa is an entirely newly formed multinational corporation with sales of EUR 12.9 billion and a workforce of some 53,400. In fiscal 2001, the corporation generated operating profits (EBITA) of more than EUR 1 billion.

Degussa's core strength lies in highly effective system solutions tailored to the requirements of its customers in over 100 countries throughout the world. Its activities are led by the vision "Everybody benefits from a Degussa product – every day and everywhere."

One of our 23 business units is Degussa BioActives, which specializes in bioactive, health-promoting substances for the food industry.

For more information, please contact Daniela Doering, head of communication, at + 49 8161 548 150 or [email protected]

This press release mentions filed and/or registered trademarks of Degussa BioActives. However, the absence of an according designation by ® or ™ should not be regarded as affecting the legal status of any of those trademarks and can not be interpreted as non-existing trademark rights.

Most Inclusive Review of MSM Published By Freedom Press

TOPANGA, CA --- Ready to be released this fall is the largest comprehensive review of MSM ever written, titled MSM‹The Definitive Guide: A Comprehensive Review of the Science and Therapeutics of Methylsulfonylmethane. The new book provides an in-depth look at the science of MSM, a wealth of case histories, and an unprecedented collection of special topics, including dosage protocols, quality considerations, veterinary applications, and more.

Two leading MSM experts, Dr. Stanley Jacob and Dr. Jeremy Appleton collaborated efforts to produce this groundbreaking work. Stanley W. Jacob, M.D., medical director for Cardinal Nutrition, Inc., is the medical doctor who pioneered the clinical use of MSM and has treated more patients with MSM than any other health professional in the world. Jeremy Appleton, N.D., director of scientific affairs for Cardinal Nutrition, Inc., is a naturopathic physician, writer, and educator in the field of evidence-based complementary and alternative medicine. He lectures internationally on clinical nutrition and is the nutrition department chair at the National College of Naturopathic Medicine.

I believe it is necessary to pass along as many of the clinical, experimental, and scientific details of my work with MSM as possible and sincerely hope it will convince investigators around the world that MSM deserves serious, reproducible, clinical studies, stated Dr. Jacob. The aim of this book is to provide the practicing clinician and the interested lay person with a practical guide to the safe and effective use of MSM‹it is a perfect reference for anyone interested in MSM¹s many benefits.

Beginning October 1, 2002, copies of the book will be sold on the Freedom Press secure online Bookstore located at, as well as on Books will be available for individual or bulk purchase via email at [email protected]

The information Freedom Press publishes is presented by independent experts, a medical advisory board of physicians, naturopaths, authors, and researchers whose sources of information include scientific studies from the world's medical and scientific literature, doctors, patients, and other clinical reports.